Cardiac Dimensions Spot on with FMR Treatment

This study adds to the growing body of evidence demonstrating the effectiveness and safety of the Carillon System in two key measurements of FMR - a significant MR reduction and favorable left ventricular remodeling, observed most recently in the REDUCE FMR trial, the first and only randomized, blinded, sham-controlled trial conducted in structural heart,” Casciaro said in a release. Cardiac Dimensions has been building itself up as a powerful competitor in the FMR market. A year ago, the company raised $39 million to build strong clinical evidence for its Carillon Mitral Contour System. And in September of last year, Cardiac Dimensions launched its pivotal trial.
Source: MDDI - Category: Medical Devices Authors: Tags: Cardiovascular Source Type: news